BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for HARMONY BIOSCIENCES · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 1

Health Issues

Issues related to the development and approval of therapies for rare diseases Pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.